Barinthus Biotherapeutics plc
BRNS
$1.20
$0.0151.27%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -12.97% | -10.43% | 4.30% | -9.91% | -9.38% |
Total Receivables | 29.97% | -45.97% | -66.04% | 271.06% | -11.36% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 26.72% | -14.47% | -17.06% | -9.59% | 53.41% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 47.26% | -8.93% | 348.71% | -25.88% | -62.63% |
Total Current Assets | -8.62% | -12.61% | -6.62% | 2.10% | -7.86% |
|
|||||
Total Current Assets | -8.62% | -12.61% | -6.62% | 2.10% | -7.86% |
Net Property, Plant & Equipment | -22.07% | -14.47% | -35.27% | -0.47% | -3.65% |
Long-term Investments | -- | -- | -- | 0.00% | 0.00% |
Goodwill | -- | -- | -- | 0.00% | 0.00% |
Total Other Intangibles | -3.73% | -3.60% | -3.47% | -3.36% | -3.25% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.66% | 2.38% | -4.86% | 4.51% | 0.11% |
Total Assets | -8.76% | -11.43% | -15.03% | 1.04% | -6.38% |
|
|||||
Total Accounts Payable | 32.65% | -45.15% | -19.57% | 20.34% | 119.97% |
Total Accrued Expenses | 2.31% | -24.43% | 19.57% | -22.49% | 23.39% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.88% | 2.08% | -3.32% | 3.65% | 0.37% |
Total Finance Division Other Current Liabilities | 4.38% | -15.94% | -14.97% | 143.62% | -41.49% |
Total Other Current Liabilities | 4.38% | -15.94% | -14.97% | 143.62% | -41.49% |
Total Current Liabilities | 6.25% | -23.51% | 3.88% | -3.32% | 21.46% |
|
|||||
Total Current Liabilities | 6.25% | -23.51% | 3.88% | -3.32% | 21.46% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -0.07% | -1.27% | -5.58% | 0.27% | -2.23% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -1.45% | 0.45% | 28.07% | -6.54% | -0.48% |
Total Liabilities | 2.56% | -12.55% | 3.30% | -2.44% | 9.08% |
|
|||||
Common Stock & APIC | -0.07% | 0.12% | 0.41% | 0.41% | 0.40% |
Retained Earnings | -8.21% | -8.27% | -9.46% | -3.88% | -8.81% |
Treasury Stock & Other | 39.21% | 18.01% | -66.71% | 37.25% | 0.66% |
Total Common Equity | -11.36% | -11.18% | -18.37% | 1.71% | -8.85% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -11.36% | -11.18% | -18.37% | 1.71% | -8.85% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 5.05% | -6.60% | -36.53% | -2.91% | -6.01% |
Total Equity | -11.34% | -11.17% | -18.39% | 1.70% | -8.85% |
|